Cooper D - Search Results

1

Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation.

Kim TK, DeVeaux M, Stahl M, Perreault S, Isufi I, Cooper D, Foss F, Shlomchik W, Zelterman D, Zeidan AM, Seropian S. Kim TK, et al. Among authors: cooper d. Ann Hematol. 2019 Jan;98(1):237-240. doi: 10.1007/s00277-018-3427-1. Epub 2018 Jul 19. Ann Hematol. 2019. PMID: 30027436 Clinical Trial. No abstract available.

2

Prospective evaluation of acute graft-versus-host disease.

Aslanian H, Chander B, Robert M, Cooper D, Proctor D, Seropian S, Jain D. Aslanian H, et al. Among authors: cooper d. Dig Dis Sci. 2012 Mar;57(3):720-5. doi: 10.1007/s10620-011-1938-x. Epub 2011 Oct 20. Dig Dis Sci. 2012. PMID: 22011927 Clinical Trial.

3

Autologous Stem Cell Mobilization in the Age of Plerixafor.

Cooper DL, Medoff E, Patel N, Baker J, Pratt K, Foss F, Seropian SE, Perreault S, Wu Y. Cooper DL, et al. Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):411-6. doi: 10.1016/j.clml.2016.04.007. Epub 2016 May 5. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27245311

4

Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administration.

Perreault S, Baker J, Medoff E, Pratt K, Foss F, Isufi I, Seropian S, Cooper DL. Perreault S, et al. Support Care Cancer. 2017 Jan;25(1):205-208. doi: 10.1007/s00520-016-3399-4. Epub 2016 Sep 10. Support Care Cancer. 2017. PMID: 27614867

5

HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic disorders.

McGuirk JP, Seropian S, Cooper D. McGuirk JP, et al. Among authors: cooper d. Cancer J Sci Am. 1998 Sep-Oct;4(5):278-86. Cancer J Sci Am. 1998. PMID: 9815289 Review. No abstract available.

6

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease.

Argiris A, Seropian S, Cooper DL. Argiris A, et al. Among authors: cooper dl. Ann Oncol. 2000 Jun;11(6):665-72. doi: 10.1023/a:1008396525292. Ann Oncol. 2000. PMID: 10942053 Free article.

7

Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.

Seropian S, Bahceci E, Cooper DL. Seropian S, et al. Among authors: cooper dl. Bone Marrow Transplant. 2003 Oct;32(8):763-9. doi: 10.1038/sj.bmt.1704233. Bone Marrow Transplant. 2003. PMID: 14520419 Clinical Trial.

8

The use of basiliximab-infliximab combination for the treatment of severe gastrointestinal acute GvHD.

Nadeau M, Perreault S, Seropian S, Foss F, Isufi I, Cooper DL. Nadeau M, et al. Among authors: cooper dl. Bone Marrow Transplant. 2016 Feb;51(2):273-6. doi: 10.1038/bmt.2015.247. Epub 2015 Oct 19. Bone Marrow Transplant. 2016. PMID: 26479982 Clinical Trial.

9

Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma.

Gibson JF, Foss F, Cooper D, Seropian S, Irizarry D, Barbarotta L, Lansigan F. Gibson JF, et al. Among authors: cooper d. Br J Haematol. 2014 Oct;167(1):141-4. doi: 10.1111/bjh.12944. Epub 2014 May 29. Br J Haematol. 2014. PMID: 24888971 Free article. No abstract available.

10

Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat.

Baker JK, Shank-Coviello J, Zhou B, Dixon J, McCorkle R, Sarpong D, Medoff E, Cooper D, Seropian S, Dai F. Baker JK, et al. Among authors: cooper d. Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):244-251.e4. doi: 10.1016/j.clml.2019.12.027. Epub 2020 Jan 18. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32067953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,676 results

Search Page

Filters